AN2 Therapeutics commences Phase 3 Part of Phase 2/3 Clinical Trial Evaluating Epetraborole for Treatment-Refractory Mycobacterium avium complex (MAC) Lung Disease read more 09/13/23
Vytelle Expands to Brisbane, Australia with Sixteenth Global Bovine In Vitro Fertilisation Laboratory read more 07/13/23
MINDERA HEALTH™ ANNOUNCES COVERAGE WITH EVIDENCE PROJECT WITH HIGHMARK, INC. TO ADVANCE MODERATE-TO-SEVERE PSORIASIS PATIENT CARE AND REDUCE SPECIALTY DRUG SPENDING read more 04/11/23
Mountain Group Partners Completes Fundraising on $128 Million MGP Venture Fund III read more 06/28/22